South Carolina S 54: Magistrates salaries

Bill Text

2025-2026 Bill 54 Text of Previous Version (Apr. 22, 2025) - South Carolina Legislature Online 

South Carolina General Assembly
126th Session, 2025-2026

Bill 54

Indicates Matter Stricken
Indicates New Matter

(Text matches printed bills. Document has been reformatted to meet World Wide Web specifications.)

Indicates Matter Stricken

Indicates New Matter

Committee Report

April 15, 2025

S. 54

Introduced by Senators Martin, Rice, Kimbrell, 
Leber, Kennedy, Nutt and Corbin 

S. Printed 4/15/25--S. [SEC 
4/22/2025 4:28 PM]

Read the first time January 14, 2025

________

The committee on Senate Medical 
Affairs

To whom was referred a Bill (S. 54) to amend 
the South Carolina Code of Laws so as to enact the "medical informed consent 
act"; by adding Section 16-17-780 so as to provide that it is unlawful for, 
etc., respectfully

Report:

That they have duly and carefully considered 
the same, and recommend that the same do pass with amendment:

 Amend 
the bill, as and if amended, SECTION 2, by striking Section 16-17-780(A)(3) and 
inserting:

 (3) "Vaccine" 
means a suspension of attenuated or killed microorganisms, or of antigenic 
proteins derived from them, that is administered for prevention or amelioration 
of infectious disease; and which has obtained Emergency Use Authorization, or which has 
been approved by the U.S. Food and Drug Administration and has been licensed 
for use.

 (4) "Novel vaccine" means a 
vaccine which has obtained Emergency Use Authorization by the U.S. Food and 
Drug Administration (FDA), or which has otherwise not been approved by the FDA, 
or which has been approved by the FDA and marketed to the public for less than 
ten years. The term "novel vaccine" does not include vaccines for which the 
contents have only been modified by antigenic subtype to address the most 
prevalent strain of virus including, but not limited to, the yearly influenza 
vaccine.

Amend 
the bill further, SECTION 2, by striking Section 16-17-780(B) and inserting:

 (B) It is unlawful 
for any person, partnership, for-profit or nonprofit corporation, limited 
liability corporation, institution of higher learning, or the State and its 
political subdivisions and their agents that employ one or more employees to 
mandate employees, contractors, students, patrons, customers, clients, or 
guests to receive a novel vaccine, 
indemnified product, or gene therapy described in this section as a 
precondition for employment, entry into buildings and grounds, attendance, 
participation, or purchase or receipt of any products and services offered.

Amend 
the bill further, SECTION 3, by striking Section 41-1-55(A)(6) and inserting:

 (6) "Vaccine" 
means a suspension of attenuated or killed microorganisms, or of antigenic 
proteins derived from them, that is administered for prevention or amelioration 
of infectious disease; and which has obtained Emergency Use Authorization, or which has 
been approved by the U.S. Food and Drug Administration, and has been licensed 
for use.

 (7) "Novel vaccine" means a 
vaccine which has obtained Emergency Use Authorization by the U.S. Food and 
Drug Administration (FDA), or which has otherwise not been approved by the FDA, 
or which has been approved by the FDA and marketed to the public for less than 
ten years. The term "novel vaccine" does not include vaccines for which the 
contents have only been modified by antigenic subtype to address the most 
prevalent strain of virus including, but not limited to, the yearly influenza 
vaccine.

Amend 
the bill further, SECTION 3, by striking Section 41-1-55(B) and inserting:

 (B) Employers are 
prohibited from taking any adverse pre-employment or employment action 
including, but not limited to, discrimination, termination, suspension, 
involuntary reassignment, unpaid leave, demotion, harassment, coercion, or 
retaliation against an individual who declines to receive a novel vaccine, indemnified product, or gene 
therapy as defined in this section.

Amend 
the bill further, SECTION 4, by striking Section 40-43-86(E)(1)(f)(6) 
and inserting:

 (f)(6) 
number of refills authorized. No prescription marked "PRN" or any other 
nonspecified number of refills may be refilled more than two years beyond the 
date it was originally written. Nothing in this subsection abridges the 
right of a pharmacist to refuse to fill or refill a prescription; and

Amend 
the bill further, SECTION 4, by deleting Section 40-43-86(E)(2) from the 
bill.

Amend 
the bill further, by adding appropriately numbered SECTIONS to read:

SECTION X. Section 
40-43-86 of the S.C. Code is amended by adding:

 (HH) (A) If a pharmacist refuses to 
fill a prescription for a patient, the pharmacy shall make a reasonable effort 
to contact the prescribing practitioner to inform them of the refusal and the 
reason for such action.

 (B) The requirement shall not apply in 
cases where:

 (1) The prescription is not being 
filled due to early refill limitations, quantity re